Streetbeat News

Price Targets

EQIX

Equinix (NASDAQ:EQIX) has been analyzed by 8 analysts, showing a range of bullish to somewhat bullish sentiments. Recent analyst actions have raised price targets, with an average target of $923, reflecting a 4.68% increase. Equinix operates 260 data centers globally, with strong revenue growth but challenges in profitability and ROE.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 9:00 pm

VEEV

17 analysts have evaluated Veeva Systems (NYSE:VEEV) over the past three months, showing a mix of bullish and bearish perspectives. The average 12-month price target has increased by 4.67% to $236.24. Analysts have mostly raised their price targets, reflecting positive sentiment towards Veeva's financial performance and market position.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 9:00 pm

AOMR

Jones Trading has initiated coverage on Angel Oak Mortgage REIT (NYSE:AOMR) with a Buy rating and set a price target of $12.5.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 8:17 pm

PRG

Analysts have provided mixed ratings for PROG Holdings (NYSE:PRG), with a majority being bullish. The average 12-month price target has increased by 17.95% to $50.33. Analysts have raised their ratings and price targets, indicating positive sentiment despite the company's recent revenue decline and below-average net margin.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 8:01 pm

OHI

Omega Healthcare Invts (NYSE:OHI) has been analyzed by 4 analysts, showing a range of sentiments from somewhat bullish to indifferent. Recent analyst actions include raised price targets, with an average target of $38.5, reflecting an 11.59% increase from the previous target. Omega Healthcare Invts is a healthcare facility REIT with strong financial metrics, including a high net margin and efficient asset management.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 8:01 pm

BWA

Over the past three months, 11 analysts have evaluated BorgWarner (NYSE:BWA), with opinions ranging from bullish to bearish. The average 12-month price target has decreased by 4.33% to $42.0. Analysts have adjusted their ratings and price targets in response to market conditions and company performance. BorgWarner faces revenue challenges but maintains strong financial health with high net margins, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

October 01, 2024 | 8:00 pm

CTSO

EF Hutton analyst Jason Kolbert has reiterated a Buy rating for CytoSorbents (NASDAQ:CTSO) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 7:50 pm

HUMA

EF Hutton analyst Jason Kolbert has reiterated a Buy rating for Humacyte (NASDAQ:HUMA) and maintained a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 7:48 pm

ELF

DA Davidson analyst Linda Bolton Weiser has reiterated a Buy rating for e.l.f. Beauty (NYSE:ELF) and maintained a price target of $223.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 7:44 pm

BKD

Macquarie analyst Tao Qiu has reiterated an 'Outperform' rating for Brookdale Senior Living (NYSE:BKD) and maintained a price target of $8.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 7:42 pm